KFx raises $10m for cuff repair:
This article was originally published in Clinica
Orthopaedic device manufacturer KFx Medical has secured $10m in a series B financing. The round was led by Alloy Ventures and contributed to by existing shareholders, Charter Life Sciences, Arboretum Ventures, Montreux Equity Partners and MB Venture Partners. The Carlsbad, California-based company will use the funds to aid distribution of its SutureCross knotless anatomic fixation system, which received FDA clearance in August 2006. SutureCross is used for the treatment of double row arthroscopic rotator cuff repair. KFx claims that torn rotator cuffs account for more than 500,000 surgeries every year.